Oral pregabalin as an add-on treatment for status epilepticus

Epilepsia

Volumn 51, Issue 10, 2010, Pages 2207-2210

  Novy, Jan ^a   Rossetti, Andrea O ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Complex partial status epilepticus; Outcome; Serum level

Indexed keywords

CLONAZEPAM; ETIRACETAM; MIDAZOLAM; PHENOBARBITAL; PHENYTOIN; PREGABALIN; PROPOFOL; TOPIRAMATE; VALPROIC ACID;

ADD ON THERAPY; ADULT; AGED; ARTICLE; DRUG TOLERABILITY; DRUG WITHDRAWAL; EPILEPTIC STATE; FEMALE; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TREATMENT RESPONSE;

ADMINISTRATION, ORAL; ADULT; AGED; AGED, 80 AND OVER; ANTICONVULSANTS; DRUG RESISTANCE; DRUG THERAPY, COMBINATION; EPILEPSIES, PARTIAL; FEMALE; GAMMA-AMINOBUTYRIC ACID; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; STATUS EPILEPTICUS; TREATMENT OUTCOME;

EID: 78649243162     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/j.1528-1167.2010.02646.x     Document Type: Article

References (12)

1. Ben-Menachem E,. (2004) Pregabalin pharmacology and its relevance to clinical practice. Epilepsia 45 (suppl 6): 13-18.
2. Booth CM, Boone RH, Tomlinson G, Detsky AS,. (2004) Is this patient dead, vegetative, or severely neurologically impaired? Assessing outcome for comatose survivors of cardiac arrest. JAMA 291: 870-879.
3. Dooley DJ, Donovan CM, Pugsley TA,. (2000) Stimulus-dependent modulation of [(3)H]norepinephrine release from rat neocortical slices by gabapentin and pregabalin. J Pharmacol Exp Ther 295: 1086-1093.
4. Drislane FW, Blum AS, Lopez MR, Gautam S, Schomer DL,. (2009) Duration of refractory status epilepticus and outcome: loss of prognostic utility after several hours. Epilepsia 50: 1566-1571.
5. Holtkamp M, Othman J, Buchheim K, Meierkord H,. (2005) Predictors and prognosis of refractory status epilepticus treated in a neurological intensive care unit. J Neurol Neurosurg Psychiatry 76: 534-539.
6. Kellinghaus C, Berning S, Besselmann M,. (2009) Intravenous lacosamide as successful treatment for nonconvulsive status epilepticus after failure of first-line therapy. Epilepsy Behav 14: 429-431.
7. Knake S, Gruener J, Hattemer K, Klein KM, Bauer S, Oertel WH, Hamer HM, Rosenow F,. (2008) Intravenous levetiracetam in the treatment of benzodiazepine refractory status epilepticus. J Neurol Neurosurg Psychiatry 79: 588-589.
8. Novy J, Logroscino G, Rossetti AO,. (2010) Refractory status epilepticus: a prospective observational study. Epilepsia 51: 251-256.
9. Ramsay RE, Perucca E, Robbins J, Barrett JA, Spiegel K,. (2009) Rapid onset of seizure suppression with pregabalin adjunctive treatment in patients with partial seizures. Epilepsia 50: 1891-1898.
10. Rossetti AO, Bromfield EB,. (2006) Determinants of success in the use of oral levetiracetam in status epilepticus. Epilepsy Behav 8: 651-654.
11. Shorvon S,. (2001) The management of status epilepticus. J Neurol Neurosurg Psychiatry 70 (suppl 2): II22-II27.
12. Towne AR, Garnett LK, Waterhouse EJ, Morton LD, DeLorenzo RJ,. (2003) The use of topiramate in refractory status epilepticus. Neurology 60: 332-334.